Springer Amends Tectonic Therapeutic 13D Filing

TL;DR

Springer updated his Tectonic Therapeutic stake filing. Watch for more details.

AI Summary

On September 26, 2024, Timothy A. Springer filed an amendment to Schedule 13D for Tectonic Therapeutic, Inc. The filing indicates a change in beneficial ownership of the company's common stock. The specific details of the change in ownership and the total number of shares held are not fully detailed in this excerpt.

Why It Matters

Amendments to Schedule 13D filings signal significant changes in ownership for public companies, potentially impacting stock price and corporate strategy.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate shifts in control or significant investment activity, warranting closer monitoring.

Key Players & Entities

• Tectonic Therapeutic, Inc. (company) — Subject Company
• Timothy A. Springer (person) — Filer
• Michael K. Bradshaw, Jr. (person) — Authorized Contact
• Nelson Mullins Riley & Scarborough LLP (company) — Legal Counsel

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
• $27.68 — of 50,000 Shares at prices ranging from $27.68 to $30.90 per share for an aggregate pu
• $30.90 — Shares at prices ranging from $27.68 to $30.90 per share for an aggregate purchase pri
• $1.4 million — gregate purchase price of approximately $1.4 million. Dr. Springer used personal funds for s

Filing Documents

• ea0215858-13da1springer_tect.htm (SC 13D/A) — 73KB
• ea021585801ex99-4_tect.htm (EX-99.4) — 4KB
• ea021585801ex99-5_tect.htm (EX-99.5) — 40KB
• 0001213900-24-082376.txt ( ) — 118KB

of the Schedule 13D is hereby amended to be supplemented by

Item 3 of the Schedule 13D is hereby amended to be supplemented by the following: On September 24, 2024, TAS distributed an aggregate of 1,240,893 Shares held by it to Dr. Springer and Dr. Lu. TAS distributed 1,054,759 Shares to Dr. Springer and 186,134 Shares to Dr. Lu. In open market purchases on September 26, 2024, Dr. Springer acquired an aggregate of 50,000 Shares at prices ranging from $27.68 to $30.90 per share for an aggregate purchase price of approximately $1.4 million. Dr. Springer used personal funds for such acquisitions. Item 5. Interest in Securities of the Issuer . The information set forth under Item 3 and the cover pages of this (a) The percentages of beneficial ownership reported in this Item 5, and on each Reporting Person’s cover page to this Schedule 13D, are based on a total of 14,734,479 Shares issued and outstanding as of August 9, 2024, as reported on the Issuer’s Quarterly Report on Form 10-Q, dated August 14, 2024. The number of Shares beneficially owned by each Reporting Person has not changed since the date of event that requires filing of this Statement. The Reporting Persons, in the aggregate, beneficially own 4,293,121 Shares, representing approximately 29.1% of such class of securities. Dr. Springer is the beneficial owner of a total of 4,293,121 Shares, representing approximately 29.1% of the outstanding Shares and consisting of (i) 3,796,764 Shares held directly, (ii) 310,223 Shares held by TAS and (iii) 186,134 Shares held by Dr. Lu. TAS is the beneficial owner of a total of 310,223 Shares, representing approximately 2.1% of the outstanding Shares. TAS holds all such Shares directly. Dr. Springer is the sole managing member of TAS. Dr. Lu is the beneficial owner of a total of 186,134 Shares, representing approximately 1.3% of the outstanding Shares. Dr. Lu holds all such Shares directly. Dr. Lu is the spouse of Dr. Springer. (b) Dr. Springer e

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: September 26, 2024 /s/ Timothy A. Springer Timothy A Springer /s/ Chafen Lu Chafen Lu TAS Partners LLC By: /s/ Timothy A. Springer Name: Timothy A. Springer Title: Manager

View Full Filing

View this SC 13D/A filing on SEC EDGAR